AbbVie Inc. Net Income Loss

• AbbVie Inc. showed a decrease of -1.2% in Net Income Loss from 2024 to 2025.
• This data is from AbbVie Inc.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
• XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 12 years of available data (2014 to 2025), AbbVie Inc.'s Net Income Loss has grown by 138.2%.
• Historical annual values: Fiscal year 2025: $4.23 billion | Fiscal year 2024: $4.28 billion | Fiscal year 2023: $4.86 billion | Fiscal year 2022: $11.84 billion | Fiscal year 2021: $11.54 billion | Fiscal year 2020: $4.62 billion | Fiscal year 2019: $7.88 billion | Fiscal year 2018: $5.69 billion | Fiscal year 2017: $5.31 billion | Fiscal year 2016: $5.95 billion | Fiscal year 2015: $5.14 billion | Fiscal year 2014: $1.77 billion.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026